Skip to Content
Merck
CN

445231

2-Methoxyphenylboronic acid

95%

Synonym(s):

(2-Methoxyphenyl)boric acid, 2-Methoxybenzeneboronic acid, o-Anisylboronic acid, o-Methoxybenzeneboronic acid, o-Methoxyphenylboronic acid

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
CH3OC6H4B(OH)2
CAS Number:
5720-06-9
Molecular Weight:
151.96
UNSPSC Code:
12352103
NACRES:
NA.06
PubChem Substance ID:
24868169
MDL number:
MFCD00236047
Beilstein/REAXYS Number:
3030981

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

2-Methoxyphenylboronic acid, 95%

InChI

1S/C7H9BO3/c1-11-7-5-3-2-4-6(7)8(9)10/h2-5,9-10H,1H3

SMILES string

COc1ccccc1B(O)O

InChI key

ROEQGIFOWRQYHD-UHFFFAOYSA-N

assay

95%

form

solid

mp

105-110 °C (lit.)

Quality Level

100

Looking for similar products? Visit Product Comparison Guide

Related Categories

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
0000200108
0000200108
WXBC7309V
02699MJV
02699MJ

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ji Gwang Yu et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 23(63), 16044-16050 (2017-08-24)
Four dibenzofuran-type host materials substituted with a carbazolylcarbazole moiety were synthesized to investigate the effect of substitution position on the material parameters and device performances of host materials. The carbazolylcarbazole moiety was substituted at the 1-, 2-, 3-, and 4-positions
Steffen Bugge et al.
European journal of medicinal chemistry, 94, 175-194 (2015-03-15)
An approach for optimization of epidermal growth factor receptor tyrosine kinase (EGFR-TK) inhibitors using truncated thienopyrimidine structures combined with enzymatic assay has been evaluated. This was done by synthesis and EGFR activity measurement of a series of fragment structures and

Related Content

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service